Implementation of pattern-mixture models in randomized clinical trials.
- Published in:
- Pharmaceutical Statistics, 2016, v. 15, n. 6, p. 494, doi. 10.1002/pst.1780
- By:
- Publication type:
- Article
Works matching IS 15391604 AND DT 2016 AND VI 15 AND IP 6
Results: 13
1
2
Estimating the reliability of repeatedly measured endpoints based on linear mixed-effects models. A tutorial.
- Published in:
- Pharmaceutical Statistics, 2016, v. 15, n. 6, p. 486, doi. 10.1002/pst.1787
- By:
- Publication type:
- Article
3
Accounting for uncertainty in the historical response rate of the standard treatment in single-arm two-stage designs based on Bayesian power functions.
- Published in:
- Pharmaceutical Statistics, 2016, v. 15, n. 6, p. 517, doi. 10.1002/pst.1788
- By:
- Publication type:
- Article
4
Issue Information.
- Published in:
- Pharmaceutical Statistics, 2016, v. 15, n. 6, p. 447, doi. 10.1002/pst.1715
- Publication type:
- Article
5
Model averaging inconcentration-QT analyses.
- Published in:
- Pharmaceutical Statistics, 2016, v. 15, n. 6, p. 450, doi. 10.1002/pst.1766
- By:
- Publication type:
- Article
6
Precise definitions of some terminology for longitudinal clinical trials: subjects, patient populations, analysis sets, intention to treat, and related terms.
- Published in:
- Pharmaceutical Statistics, 2016, v. 15, n. 6, p. 471, doi. 10.1002/pst.1767
- By:
- Publication type:
- Article
7
Generalized optimal design for two-arm, randomized phase II clinical trials with endpoints from the exponential dispersion family.
- Published in:
- Pharmaceutical Statistics, 2016, v. 15, n. 6, p. 459, doi. 10.1002/pst.1769
- By:
- Publication type:
- Article
8
Effect of design specifications in dose-finding trials for combination therapies in oncology.
- Published in:
- Pharmaceutical Statistics, 2016, v. 15, n. 6, p. 531, doi. 10.1002/pst.1770
- By:
- Publication type:
- Article
9
Randomized phase II cancer clinical trials.
- Published in:
- Pharmaceutical Statistics, 2016, v. 15, n. 6, p. 560, doi. 10.1002/pst.1771
- By:
- Publication type:
- Article
10
Dynamical Biostatistical Models.
- Published in:
- Pharmaceutical Statistics, 2016, v. 15, n. 6, p. 561, doi. 10.1002/pst.1772
- By:
- Publication type:
- Article
11
Simulation-based sample-sizing and power calculations in logistic regression with partial prior information.
- Published in:
- Pharmaceutical Statistics, 2016, v. 15, n. 6, p. 507, doi. 10.1002/pst.1773
- By:
- Publication type:
- Article
12
A novel approach to estimation of the time to biomarker threshold: applications to HIV.
- Published in:
- Pharmaceutical Statistics, 2016, v. 15, n. 6, p. 541, doi. 10.1002/pst.1774
- By:
- Publication type:
- Article
13
Some practical considerations in three-arm non-inferiority trial design.
- Published in:
- Pharmaceutical Statistics, 2016, v. 15, n. 6, p. 550, doi. 10.1002/pst.1779
- By:
- Publication type:
- Article